BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Ingrid Mayer, MD, Vanderbilt-Ingram Cancer Center Identifier:
First received: February 11, 2013
Last updated: July 31, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: October 2017 (Final data collection date for primary outcome measure)